Akers Biosciences Inc AKR:LSE 
| 13.25GBX Last Price | -0.25 -1.85% Today's Change | 95.52k Shares Traded | 10.75-28.00 52 Week Range | -1.00 -7.02% 52 Week Change | 0.6475 Beta |
Akers Biosciences Inc Summary
| Open | 13.50 | Average Volume | 52.22k | |
| Day High | 13.50 | EPS (TTM) | -0.641GBX | |
| Day Low | 13.25 | Div PS (TTM) | -- | |
| Previous Close | 13.25 | Div Yield | -- | |
| Shares Outstanding | 113.50m | Div Ex-Date | -- | |
| Market Cap | 15.26mGBP | Div Pay-Date | -- | |
| Free Float | 57.68m | Next Div Ex-Date | -- | |
| P/E (TTM) | -- | Next Div Pay-Date | -- | |
As of last close on Feb 09 2010, Akers Biosciences Inc (AKR:LSE) closed at 13.25, 23.26% above the 52 week low of 10.75 set on November 11, 2009.
Comparative Analysis
Over the last five years Akers Biosciences Inc (AKR:LSE) consistently underperformed the FTSE 100 index.
| Name | 1 Week | 1 Month | 6 Month | 1 Year | 5 Year |
|---|---|---|---|---|---|
| Akers Biosciences Inc AKR:LSE | -14.52% | -23.19% | -42.39% | -7.02% | -79.13% |
| FTSE 100 | -3.25% | -7.63% | +9.43% | +18.67% | +2.43% |
© Thomson Reuters Click for restrictions.
All markets data located on FT.com is subject to the FT Terms & Conditions.
All content on FT.com is for your general information and use only and is not intended to address your particular requirements.In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time".Share price information may be rounded up/down and therefore not entirely accurate.FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.